当前位置: 首页 > 期刊 > 《心脑血管病防治》 > 2017年第6期
编号:13211590
阿加曲班治疗发病6小时以上急性脑梗死患者的临床分析(3)
http://www.100md.com 2017年12月1日 心脑血管病防治 2017年第6期
     [10]Khatri P, Yeatts SD, Mazighi M, et al. Time to angiographic reperfusion and clinical outcome after acute ischaemic stroke: an analysis of data from the Interventional Management of Stroke (IMS III) phase 3 trial[J]. Lancet Neurol,2014,13(6):567-574.

    [11]Fujimori Y, Wakui M, Katagiri H, et al. Evaluation of anticoagulant effects of direct thrombin inhibitors, dabigatran and argatroban, based on the Lineweaver_Burk plot applied to the Clauss assay[J]. J Clin Pathol,2016,69(4):370-372.

    [12]Sandercock PA, Counsell C, Kamal AK. Anticoagulants for acute ischemic stroke[J]. Cochrane Database Syst Rev,2008,8(4):CD000024.

    [13]孫福海.阿加曲班联合依达拉奉对急性脑梗死患者血清和肽素及N末端脑钠肽前体的影响[J].中国实用神经疾病杂志,2017,20(2):109-111.

    [14]LaMonte MP, Nash ML, Wang DZ, et al. Argatroban anticoagulation in patients with acute ischemic stroke (ARGIS_1): a randomized, placebo_controlled safety study[J]. Stroke,2004,35(7):1677-1682.

    [15]Berkhemer OA, Fransen PS, Beumer D, et al. A randomized trial of intraarterial treatment for acute ischemic stroke[J]. N Engl J Med,2015,372(1):11-20.

    (收稿日期:2017_7_18), 百拇医药(方兰)
上一页1 2 3